CH
Carl Hansen
Chairman, CEO & President
AbCelleraAbCellera Pipeline
| Drug | Indication | Phase |
|---|
| ABCL635 | Vasomotor Symptoms (VMS) associated with menopause | Phase 1/2 |
| ABCL575 | Moderate-to-Severe Atopic Dermatitis (AD) | Phase 1 |
| ABCL688 | Undisclosed Autoimmune Indication | IND-Enabling |
| ABCL386 | Undisclosed Oncology Indication | Discovery |